For citations:
Belousova E.A., Abdulkhakov R.A., Bakulin I.G., Kulyapin A.V., Tkachev A.V., Marano C., Miao Ye. Efficacy and safety of ustekinumab in Russian bionaive patients with moderately to severely active ulcerative colitis: a subanalys is of global phase 3 induction and maintenance studies (UNIFI) up to 3 years. Koloproktologia. 2023;22(1):54-64. https://doi.org/10.33878/2073-7556-2023-22-1-54-64
Views PDF (Eng): 272